TOKYO, Aug 25 (Reuters) - Japanese shares rose on Tuesday, trading close to levels before the COVID-19 crisis hammered markets early this year, as new developments on the COVID-19 vaccine and treatment fronts lifted sentiment and spurred hopes of a quicker economic recovery.
The benchmark Nikkei share average .N225 gained 1.71% to 23,378.47 by the midday break, just a hair below 23,386.74, and a level unseen since Feb. 21. There were 216 advancers on the index against nine decliners.
The broader Topix .TOPX gained 1.51% to 1,631.33. All but two of the 33 sector sub-indexes on the Tokyo exchange traded higher, with airlines .IAIRL.T , textiles .ITXTL.T and insurance .IINSU.T being the three top performers.
All three major indexes on Wall Street closed higher overnight as President Donald Trump hailed the U.S. Food and Drug Administration's authorisation of a COVID-19 treatment that uses blood plasma from recovered patients. Trump administration was also considering fast-tracking an experimental COVID-19 vaccine, the Financial Times reported. additional support to risk appetite, Japan's capital Tokyo reported 95 new coronavirus cases on Monday, the lowest single-day tally since July 8. worries over U.S.-China relations eased as the U.S. Trade Representative's Office said top U.S. and Chinese officials saw progress on resolving issues over the Phase 1 trade deal, and both sides were committed to the success of the agreement. top performing sectors, airlines rose 5.81% after U.S.-listed peers jumped overnight. ANA Holdings 9202.T climbed 6.44%, while Japan Airlines 9201.T added 5.07%.
Nintendo 7974.T hit a 12-year high before reversing course to trade 1.73% lower on profit-taking.
Add Chart to Comment
We encourage you to use comments to engage with users, share your perspective and ask questions of authors and each other. However, in order to maintain the high level of discourse we’ve all come to value and expect, please keep the following criteria in mind:
- Enrich the conversation
- Stay focused and on track. Only post material that’s relevant to the topic being discussed.
- Be respectful. Even negative opinions can be framed positively and diplomatically.
- Use standard writing style. Include punctuation and upper and lower cases.
- NOTE: Spam and/or promotional messages and links within a comment will be removed
- Avoid profanity, slander or personal attacks directed at an author or another user.
- Don’t Monopolize the Conversation. We appreciate passion and conviction, but we also believe strongly in giving everyone a chance to air their thoughts. Therefore, in addition to civil interaction, we expect commenters to offer their opinions succinctly and thoughtfully, but not so repeatedly that others are annoyed or offended. If we receive complaints about individuals who take over a thread or forum, we reserve the right to ban them from the site, without recourse.
- Only English comments will be allowed.
Perpetrators of spam or abuse will be deleted from the site and prohibited from future registration at Investing.com’s discretion.